Keyphrases
Confidence Interval
100%
Body Mass Index
67%
Multiple Myeloma
63%
Stage I Lung Cancer
55%
Obesity
54%
Surgical Treatment
53%
Overall Survival
53%
Kidney Transplant
48%
Racial Disparities
47%
Cost-effectiveness Analysis
46%
United States
45%
Early-stage Lung Cancer
39%
Veterans Health Administration
38%
Non-small Cell Lung Cancer (NSCLC)
38%
Bariatric Surgery
37%
Simultaneous Pancreas-kidney Transplantation
37%
Clinical Stage I
36%
Liver Transplantation
36%
Adjusted Odds Ratio
36%
Quality-adjusted Life Years
35%
Monoclonal Gammopathy of Undetermined Significance
33%
US Veterans
32%
National Health Interview Survey
31%
Improved Survival
31%
Hazard Ratio
30%
Type 1 Diabetes Mellitus (T1DM)
30%
Metformin Use
28%
Years of Life Lost
28%
Multivariable
27%
Pancreas Allograft
26%
Kidney
26%
Adjusted Hazard Ratio
25%
Diabetes
24%
Meta-analysis
24%
Cost-effectiveness
23%
Kidney Transplantation
23%
Non-Hispanic White
23%
African American
22%
Kidney Transplant Recipients
22%
Comorbidity
21%
Graft Function
21%
Systematic Meta-analysis
21%
Hepatitis C Virus
21%
Graft Failure
21%
Weight Loss
20%
Transplantation
19%
High Risk
18%
Retrospective Cohort Study
18%
Patient Characteristics
17%
Black Men
17%
Medicine and Dentistry
Surgery
77%
Kidney Graft
77%
Health Care Cost
69%
Non Small Cell Lung Cancer
69%
Transplantation
63%
Cost-Effectiveness Analysis
60%
Overall Survival
55%
Clinical Stage
54%
Body Mass Index
49%
Lung Cancer
47%
Malignant Neoplasm
44%
Liver Transplantation
43%
Multiple Myeloma
43%
Hazard Ratio
41%
Odds Ratio
41%
Bariatric Surgery
37%
Allograft
36%
Quality Adjusted Life Year
30%
Kidney Pancreas Transplantation
28%
Monoclonal Gammopathy of Undetermined Significance
27%
Diabetes
27%
Veterans Health
26%
Kidney Transplantation
26%
Racial Disparity
24%
Retrospective Cohort Study
24%
Meta-Analysis
23%
Breast Cancer
22%
Hepatitis C Virus
21%
Hepatitis C
21%
Lung Transplantation
21%
Prostate Cancer
21%
Ethnic Disparity
21%
Systematic Review
21%
Drug Therapy
18%
Graft Failure
18%
Lymph Node
18%
Pancreas Transplantation
17%
Postoperative Complication
17%
Diabetes Mellitus
17%
Disease
16%
Roux-en-Y Gastric Bypass
15%
Chemoradiotherapy
14%
Neoplasm
14%
Cohort Analysis
14%
Hepatocellular Carcinoma
14%
Insulin Dependent Diabetes Mellitus
14%
Liver Graft
14%
Radiation Therapy
14%
Glycon
14%
Hysterectomy
14%